<DOC>
	<DOCNO>NCT03104374</DOCNO>
	<brief_summary>This Phase 3 multicenter study include two period . Period 1 design compare safety , tolerability , efficacy ABT-494 Dose A daily ( QD ) Dose B QD versus placebo participant moderately severely active Psoriatic Arthritis ( PsA ) inadequate response Biological Disease Modifying Anti-Rheumatic Drug ( bDMARDs ) . Period 2 evaluates safety , tolerability efficacy ABT-494 Dose A QD Dose B QD subject PsA complete Period 1 .</brief_summary>
	<brief_title>A Study Comparing ABT-494 Placebo Participants With Active Psoriatic Arthritis Who Have History Inadequate Response Least One Biologic Disease Modifying Anti-Rheumatic Drug</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Arthritis , Psoriatic</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>Clinical diagnosis PsA symptom onset least 6 month prior Screening Visit fulfillment Classification Criteria PsA ( CASPAR ) criteria Participant active disease Baseline define &gt; = 3 tender joint ( base 68 joint count ) &gt; = 3 swollen joint ( base 66 joint count ) Screening Baseline Visits Diagnosis active plaque psoriasis document history plaque psoriasis Participant inadequate response ( lack efficacy minimum 12 week duration therapy ) intolerance treatment least 1 bDMARD . Prior exposure Janus Kinase ( JAK ) inhibitor ( include limit ruxolitinib , tofacitinib , baricitinib , filgotinib ) Current treatment &gt; 2 nonbiologic DMARDs use DMARDs Methotrexate ( MTX ) , Sulfasalazine ( SSZ ) , Leflunomide ( LEF ) , apremilast , Hydroxychloroquine ( HCQ ) , bucillamine iguratimod use MTX combination LEF Baseline . History fibromyalgia , arthritis onset prior age 17 year , current diagnosis inflammatory joint disease PsA ( include , limited gout , overlap connective tissue disease , scleroderma , polymyositis , dermatomyositis , systemic lupus erythematosus ) . Prior history reactive arthritis axial spondyloarthritis include ankylose spondylitis nonradiographic axial spondyloarthritis permit documentation change diagnosis PsA additional diagnosis PsA make . Prior history fibromyalgia permit documentation change diagnosis PsA documentation diagnosis fibromyalgia make incorrectly .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Musculoskeletal disease</keyword>
	<keyword>Joint disease</keyword>
	<keyword>Anti-Rheumatic</keyword>
	<keyword>Anti-inflammatory</keyword>
	<keyword>Psoriasis</keyword>
	<keyword>Arthritis</keyword>
</DOC>